Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Phase 3
×
Endometrial Neoplasms
×
Docetaxel
×
Clear all
Filters
3
NCT06952504
2026-04-13
TroFuse-033
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,123 enrolled
NCT06989112
2026-04-08
DE-01
AstraZeneca
Phase 3
Recruiting
600 enrolled
NCT06340568
2026-03-31
Fern-EC-01
BioNTech SE
Phase 3
Recruiting
480 enrolled
NCT04634877
2025-06-09
KEYNOTE-B21
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
990 enrolled
NCT05173987
2024-11-21
KEYNOTE-C93
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
280 enrolled